Chapter

Development of new therapeutic agents for treatment of NSCLC

Arun Rajan and Giuseppe Giaccone

in Systemic Treatment of Non-Small Cell Lung Cancer

Published on behalf of Oxford University Press

ISBN: 9780199580484
Published online March 2012 | e-ISBN: 9780199607532 | DOI: http://dx.doi.org/10.1093/med/9780199580484.003.0008

Series: Oxford Oncology Library

Development of new therapeutic agents for treatment of NSCLC

Show Summary Details

Preview

• Biologic therapies have become part of standard treatment of advanced NSCLC • Novel biologic therapies are being developed for the treatment of NSCLC • Targeting of ALK translocations has shown striking initial results in the treatment of tumors harboring ALK translocations/fusion events • Clinical trials will have to be developed to evaluate the combination of cytotoxic chemotherapy and newer biologic therapies

Chapter.  6966 words. 

Subjects: Medical Oncology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.